Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles

por Bueno, Ana B., Showalter, Aaron D., Wainscott, David B., Stutsman, Cynthia, Marín, Aranzazu, Ficorilli, James, Cabrera, Over, Willard, Francis S., Sloop, Kyle W.
Publicado 2016

Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist

por Kawai, Takahiro, Sun, Bingfa, Yoshino, Hitoshi, Feng, Dan, Suzuki, Yoshiyuki, Fukazawa, Masanori, Nagao, Shunsuke, Wainscott, David B., Showalter, Aaron D., Droz, Brian A., Kobilka, Tong Sun, Coghlan, Matthew P., Willard, Francis S., Kawabe, Yoshiki, Kobilka, Brian K., Sloop, Kyle W.
Publicado 2020

The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets

por El, Kimberley, Douros, Jonathan D., Willard, Francis S., Novikoff, Aaron, Sargsyan, Ashot, Perez-Tilve, Diego, Wainscott, David B., Yang, Bin, Chen, Alex, Wothe, Donald, Coupland, Callum, Tschöp, Mattias H., Finan, Brian, D’Alessio, David A., Sloop, Kyle W., Müller, Timo D., Campbell, Jonathan E.
Publicado 2023

Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist

por Willard, Francis S., Douros, Jonathan D., Gabe, Maria B.N., Showalter, Aaron D., Wainscott, David B., Suter, Todd M., Capozzi, Megan E., van der Velden, Wijnand J.C., Stutsman, Cynthia, Cardona, Guemalli R., Urva, Shweta, Emmerson, Paul J., Holst, Jens J., D’Alessio, David A., Coghlan, Matthew P., Rosenkilde, Mette M., Campbell, Jonathan E., Sloop, Kyle W.
Publicado 2020